Follow
begoña taboada valladares
begoña taboada valladares
Médico adjunto, Oncología Radioterápica en Santiago de Compostela
Verified email at sergas.es
Title
Cited by
Cited by
Year
REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
P Seibold, A Webb, ME Aguado-Barrera, D Azria, C Bourgier, M Brengues, ...
Radiotherapy and Oncology 138, 59-67, 2019
662019
External validation of a predictive model for acute skin radiation toxicity in the REQUITE breast cohort
T Rattay, P Seibold, ME Aguado-Barrera, M Altabas, D Azria, GC Barnett, ...
Frontiers in oncology 10, 575909, 2020
142020
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
SL Kerns, AA Morlang, SM Lee, DR Peterson, B Marples, H Zhang, ...
Radiotherapy and Oncology 168, 75-82, 2022
92022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
AJ Webb, E Harper, T Rattay, ME Aguado-Barrera, D Azria, C Bourgier, ...
EBioMedicine 84, 2022
62022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of …
L van der Weijst, D Azria, P Berkovic, P Boisselier, E Briers, R Bultijnck, ...
Radiotherapy and Oncology 176, 127-137, 2022
52022
(Pre) treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
JC Rosas, ME Aguado‐Barrera, D Azria, E Briers, R Elliott, ...
International journal of cancer 153 (9), 1579-1591, 2023
42023
Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients
ME Aguado-Barrera, L Martínez-Calvo, J Fernández-Tajes, ...
Cancers 13 (6), 1447, 2021
32021
Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician …
M Costa Rivas, G Huidobro Vence, JL Fírvida Pérez, B Campos Balea, ...
Clinical and Translational Oncology 20, 1467-1473, 2018
32018
PD-0531 SNPS IN DNA REPAIR AND DAMAGE DETECTION GENES AND ACUTE NORMAL TISSUE TOXICITY IN PROSTATE CANCER PATIENTS
L Fachal, A Gomez-Caamano, P Peleteiro, A Carballo, P Calvo-Crespo, ...
Radiotherapy and Oncology, S213, 2012
12012
Reply to: Comments on"(Pre) treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"
JC Rosas, ME Aguado-Barrera, D Azria, E Briers, R Elliott, ...
International journal of cancer 154 (4), 759-761, 2024
2024
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
E Naderi, ME Aguado-Barrera, LMH Schack, L Dorling, T Rattay, L Fachal, ...
JNCI Cancer Spectrum 7 (6), pkad088, 2023
2023
Large-Scale Meta-GWAS Reveals Common Genetic Factors Linked to Radiation-Induced Acute Toxicities across Cancers
E Naderi, ME Aguado-Barrera, LMH Schack, L Dorling, T Rattay, L Fachal, ...
JNCI cancer spectrum 7 (6), pkad088, 2023
2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
HK Jandu, CD Veal, L Fachal, C Luccarini, ME Aguado-Barrera, ...
Radiotherapy and Oncology 187, 109806, 2023
2023
Radiogenomics in lung cancer: Where are we?
ME Aguado-Barrera, P Sosa-Fajardo, A Gómez-Caamaño, ...
Lung Cancer 176, 56-74, 2023
2023
Radiation Therapy for Metastatic Lung Cancer: Bone Metastasis and Metastatic Spinal Cord Compression
B Taboada-Valladares, P Calvo-Crespo, A Gómez-Caamaño
Advances in Radiation Oncology in Lung Cancer, 779-793, 2022
2022
Palliative radiotherapy in CRC
P Calvo-Crespo, B Taboada-Valladares, A Gómez-Caamaño
Foundations of Colorectal Cancer, 429-433, 2022
2022
Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience
B Taboada Valladares, P Calvo Crespo, A Gomez Caamano, ...
JOURNAL OF THORACIC ONCOLOGY 10 (9), S743-S743, 2015
2015
Calidad de vida después recidiva bioquímica en los pacientes con cáncer de próstata.¿ Cómo y cuánto viven los pacientes después de recidiva bioquímica?
A Gómez Caamaño, L León Mateos, E Fernández Fernández, ...
Arch. esp. urol.(Ed. impr.), 193-206, 2012
2012
PO-320 SINGLE FRACTION (7 GY) OF HDR-BRACHYTHERAPY AS BOOST IN BREAST-CONSERVING THERAPY: 5 YEARS RESULTS IN 139 PATIENTS
B Taboada Valladares, E Gonzlez Patino, N Salvador Garrido, ...
Radiotherapy and Oncology 103 (2), 1, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–19